Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Clinical trial NCT05500508 · TERMINATED

Trial details

NCT number: NCT05500508
Sponsor: Aminex Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Solid Tumor Solid Carcinoma Advanced Cancer DIPG Brain Tumor Ovary Cancer Breast Cancer Papillary Thyroid Cancer Head and Neck Cancer Gastric Cancer Nsclc Mesotheliomas Pleural

Start date: 2022-11-29
Primary completion: 2024-12-12
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.